Strategies to Improve Access to and Utilization of Health Care Services and Adherence to Antiretroviral Therapy Among HIV-Infected Drug Users

REFERENCES

• Altice, F. L., Friedland, G. H., & Cooney, E. L. (1999). Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone. AIDS, 13, 957– 962.
   PubMed Web of Science ®Google Scholar
• Altice, F. L., Mezger, J. A., Hodges, J., Bruce, R. D., Marinovich, A., Walton, M., (2004). Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clinical Infectious Diseases, 38(Suppl. 5), S376–S387.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders—Fourth edition. Washington, DC: Author.
   Google Scholar
• Arnsten, J. H., Berg, K. M., Cooperman, N. A., Villanueva, M., Li, X., Parker, F., (2007, March). A 6-month randomized controlled trial of directly observed therapy delivered in methadone clinics. Poster presented at the Second International Conference on HIV Treatment Adherence, Jersey City, NJ.
   Google Scholar
• Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381.
   PubMed Web of Science ®Google Scholar
• Babudieri, S., Aceti, A., D'Offizi, G. P., Carbonara, S., & Starnini, G. (2000). Directly observed therapy to treat HIV infection in prisoners. Journal of the American Medical Association, 284, 179–180.
   PubMed Web of Science ®Google Scholar
• Bart, P. A., Rizzardi, P. G., Gallant, S., Golay, K. P., Baumann, P., Pantaleo, G., (2001). Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir. Therapeutic Drug Monitoring, 23, 553–555.
   PubMed Web of Science ®Google Scholar
• Beauverie, P., Taburet, A. M., Dessalles, M. C., Furlan, V., & Touzeau, D. (1998). Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors. AIDS, 12, 2510–2511.
   PubMed Web of Science ®Google Scholar
• Berg, K. M., Demas, P. A., Howard, A. A., Schoenbaum, E. E., Gourevitch, M. N., & Arnsten, J. H. (2004). Gender differences in factors associated with adherence to antiretroviral therapy. Journal of General Internal Medicine, 19, 1111–1117.
   PubMed Web of Science ®Google Scholar
• Bradford, J. B., Coleman, S., & Cunningham, W. (2007). HIV system navigation: An emerging model to imrpove HIV care access. AIDS Patient Care and STDs, 21, S49–S58.
   PubMed Web of Science ®Google Scholar
• Broadhead, R. S., Heckathorn, D. D., Altice, F. L., van Hulst, Y., Carbone, M., Friedland, G. H., (2002). Increasing drug users’ adherence to HIV treatment: Results of a peer-driven intervention feasibility study. Social Science & Medicine, 55, 235–246.
   PubMed Web of Science ®Google Scholar
• Cabral, H. J., Tobias, C., Rajabiun, S., Sohler, N., Cunningham, C., Wong, M., (2007). Outreach program contacts: Do they increase the likelihood of engagement and retention in HIV primary care for hard-to-reach patients? AIDS Patient Care and STDs, 21(Suppl. 1), S59–S67.
   PubMed Web of Science ®Google Scholar
• Case Management Society of America. (2007). Definition of case management. Retrieved July 3, 2007, from http://www.cmsa.org/Default.aspx?tabid =104
   Google Scholar
• Cejtin, H. E., Komaroff, E., Massad, L. S., Korn, A., Schmidt, J. B., Eisenberger-Matiyahu, D., (1999). Adherence to colposcopy among women with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 22, 247–252.
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Galai, N., Sethi, A. K., Shah, N. G., Strathdee, S. A., Vlahov, D., (2001). Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS, 15, 1707–1715.
   PubMed Web of Science ®Google Scholar
• Celentano, D. D., Vlahov, D., Cohn, S., Shadle, V. M., Obasanjo, O., & Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 544–546.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2008). HIV/AIDS surveillance report, 2006. Vol. 18. Atlanta, GA: US Department of Health and Human Services. Retrieved March 25, 2009, from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/
   Google Scholar
• Chaulk, C. P., & Kazandjian, V. A. (1998). Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus statement of the Public Health Tuberculosis Guidelines Panel. Journal of the American Medical Association, 279, 943–948.
   PubMed Web of Science ®Google Scholar
• Clarke, S., Keenan, E., Ryan, M., Barry, M., & Mulcahy, F. (2002). Directly observed antiretroviral therapy for injection drug users with HIV infection. AIDS Reader, 12, 305–306.
   PubMedGoogle Scholar
• Clarke, S., Mulcahy, F., Bergin, C., Reynolds, H., Boyle, N., Barry, M., (2002). Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir. Clinical Infectious Diseases, 34, 1143–1145.
   PubMed Web of Science ®Google Scholar
• Clarke, S. M., Mulcahy, F. M., Tjia, J., Reynolds, H. E., Gibbons, S. E., Barry, M. G., (2001a). The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. British Journal of Clinical Pharmacology, 51, 213–217.
   Google Scholar
• Clarke, S. M., Mulcahy, F. M., Tjia, J., Reynolds, H. E., Gibbons, S. E., Barry, M. G., (2001b). Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users. Clinical Infectious Diseases, 33, 1595–1597.
   PubMed Web of Science ®Google Scholar
• Cohen, M. H., Cook, J. A., Grey, D., Young, M., Hanau, L. H., Tien, P., (2004). Medically eligible women who do not use HAART: The importance of abuse, drug use, and race. American Journal of Public Health, 94, 1147–1151.
   PubMed Web of Science ®Google Scholar
• Conway, B., Prasad, J., Reynolds, R., Farley, J., Jones, M., Jutha, S., (2004). Directly observed therapy for the management of HIV-infected patients in a methadone program. Clinical Infectious Diseases, 38(Suppl. 5), S402–S408.
   PubMed Web of Science ®Google Scholar
• Cook, R. L., Sereika, S. M., Hunt, S. C., Woodward, W. C., Erlen, J. A., & Conigliaro, J. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine, 16, 83–88.
   PubMed Web of Science ®Google Scholar
• Crisp, B. R., Williams, M., Timpson, S., & Ross, M. W. (2004). Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. AIDS and Behavior, 8, 199–206.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O., Giovanniello, A., Sacajiu, G., Whitley, S. D., Mund, P., Beil, R., (2008). Buprenorphine treatment in an urban community health center: What to expect. Family Medicine, 40, 500–506.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O., Kunins, H. V., Roose, R. J., Elam, R. T., & Sohler, N. L. (2007). Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians. Journal of General Internal Medicine, 22, 1325–1329.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O., Sanchez, J. P., Heller, D. I., & Sohler, N. L. (2007). Assessment of a medical outreach program to improve access to HIV care among marginalized individuals. American Journal of Public Health, 97, 1758–1761.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O., Sanchez, J. P., Li, X., Heller, D., & Sohler, N. L. (2008). Medical and support service utilization in a medical program targeting marginalized HIV-infected individuals. Journal of Health Care for the Poor and Underserved, 19, 981–990.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O., Shapiro, S., Berg, K. M., Sacajiu, G., Paccione, G., & Goulet, J. L. (2005). An evaluation of a medical outreach program targeting unstably housed HIV-infected individuals. Journal of Health Care for the Poor and Underserved, 16, 127–138.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O., Sohler, N. L., Berg, K. M., Shapiro, S., & Heller, D. (2006). Type of substance use and access to HIV-related health care. AIDS Patient Care and STDs, 20, 399–407.
   PubMed Web of Science ®Google Scholar
• Cunningham, C. O., Sohler, N. L., Wong, M. D., Relf, M., Cunningham, W. E., Drainoni, M. L., (2007). Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care and STDs, 21, 177–186.
   PubMed Web of Science ®Google Scholar
• Ding, L., Landon, B. E., Wilson, I. B., Wong, M. D., Shapiro, M. F., & Cleary, P. D. (2005). Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Archives of Internal Medicine, 165, 618–623.
   PubMed Web of Science ®Google Scholar
• Dohan, D., & Schrag, D. (2005). Using navigators to improve care of underserved patients: Current practices and approaches. Cancer, 104, 848–855.
   PubMed Web of Science ®Google Scholar
• Emlet, C. A., & Gusz, S. S. (1998). Service use patterns in HIV/AIDS case management: A five-year study. Journal of Case Management, 7, 3–9.
   PubMedGoogle Scholar
• Fisher, J. D., Fisher, W. A., Bryan, A. D., & Misovich, S. J. (2002). Information-motivation-behavioral skills model-based HIV risk behavior change intervention for inner-city high school youth. Health Psychology, 21, 177–186.
   PubMed Web of Science ®Google Scholar
• Fisher, J. D., Fisher, W. A., Misovich, S. J., Kimble, D. L., & Malloy, T. E. (1996). Changing AIDS risk behavior: Effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population. Health Psychology, 15, 114–123.
   PubMed Web of Science ®Google Scholar
• Fisher, J. D. F., Fisher, W. A. F., Williams, S. S. F., & Malloy, T. E. (1994). Empirical tests of an information-motivation-behavioral skills model of AIDS-preventive behavior with gay men and heterosexual university students. Health Psychology, 13, 238–250.
   PubMed Web of Science ®Google Scholar
• Fleishman, J. A., Gebo, K. A., Reilly, E. D., Conviser, R., Mathews, W. C., Korthuis, P. T., (2005). Hospital and outpatient health services utilization among HIV-infected adults in care 2000–2002. Medical Care, 43, 40–52.
   Web of Science ®Google Scholar
• Fowler, T., Steakley, C., Garcia, A. R., Kwok, J., & Bennett, L. M. (2006). Reducing disparities in the burden of cancer: The role of patient navigators. PLoS Medicine, 3, e193.
   PubMed Web of Science ®Google Scholar
• Frank, B. (2000). An overview of heroin trends in New York City: Past, present and future. Mount Sinai Journal of Medicine, 67, 340–346.
   PubMed Web of Science ®Google Scholar
• Frank, B., & Galea, J. (1996). Cocaine trends and other drug trends in New York City, 1986–1994. Journal of Addictive Diseases, 15, 1–12.
   PubMed Web of Science ®Google Scholar
• Gardner, L. I., Metsch, L. R., Anderson-Mahoney, P., Loughlin, A. M., del Rio, C., Strathdee, S., (2005). Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS, 19, 423–431.
   PubMed Web of Science ®Google Scholar
• Garland, W. H., Wohl, A. R., Valencia, R., Witt, M. D., Squires, K., Kovacs, A., (2007). The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California. AIDS Care, 19, 159–167.
   PubMed Web of Science ®Google Scholar
• Gerber, J. G., Rosenkranz, S., Segal, Y., Aberg, J., D'Amico, R., Mildvan, D., (2001). Effect of ritonavir/saquinavir on stereoselective pharmacokinetics of methadone: Results of AIDS Clinical Trials Group (ACTG) 401. Journal of Acquired Immune Deficiency Syndromes, 27, 153–160.
   PubMed Web of Science ®Google Scholar
• Giordano, T. P., Visnegarwala, F., White, A. C., Troisi, C. L., Frankowski, R. F., Hartman, C. M., (2005). Patients referred to an urban HIV clinic frequently fail to establish care: Factors predicting failure. AIDS Care, 17, 773–783.
   PubMed Web of Science ®Google Scholar
• Halkitis, P. N., Kutnick, A. H., & Slater, S. (2005). The social realities of adherence to protease inhibitor regimens: Substance use, health care and psychological states. Journal of Health Psychology, 10, 545–558.
   PubMed Web of Science ®Google Scholar
• Harris, S. K., Samples, C. L., Keenan, P. M., Fox, D. J., Melchiono, M. W., & Woods, E. R. (2003). Outreach, mental health, and case management services: Can they help to retain HIV-positive and at-risk youth and young adults in care? Maternal and Child Health Journal, 7, 205–218.
   PubMedGoogle Scholar
• Health Resources Services Administration. (2007a). HIV/AIDS Bureau, Ryan White HIV/AIDS Programs Title I FY05 final expenditures report. Retrieved July 29, 2007, from ftp://ftp.hrsa.gov/hab/Title%20I%20Final%2005%20web.pdf
   Google Scholar
• Health Resources Services Administration. (2007b). HIV/AIDS Bureau, Ryan White HIV/AIDS Programs Title II FY05 final expenditures report. Retrieved July 29, 2007, from ftp://ftp.hrsa.gov/hab/Title%20II%20Expenditures%20FY2005% 20web.pdf
   Google Scholar
• Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11, 185–194.
   PubMed Web of Science ®Google Scholar
• Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care, 16, 199–211.
   PubMed Web of Science ®Google Scholar
• Jayaweera, D. T., Kolber, M. A., Brill, M., Tanner, T., Campo, R., Rodriguez, A., (2004). Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naive patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy. HIV Medicine, 5, 364–370.
   PubMed Web of Science ®Google Scholar
• Kalichman, S. C., Graham, J., Luke, W., & Austin, J. (2002). Perceptions of health care among persons living with HIV/AIDS who are not receiving antiretroviral medications. AIDS Patient Care and STDs, 16, 233–240.
   PubMed Web of Science ®Google Scholar
• Kang, S. Y., Goldstein, M. F., & Deren, S. (2006). Health care utilization and risk behaviors among HIV positive minority drug users. Journal of Health Care for the Poor and Underserved, 17, 265–275.
   PubMed Web of Science ®Google Scholar
• Kapadia, F., Vlahov, D., Wu, Y., Cohen, M. H., Greenblatt, R. M., Howard, A. A., (2008). Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. American Journal of Drug and Alcohol Abuse, 34, 161–170.
   PubMed Web of Science ®Google Scholar
• Katz, M. H., Cunningham, W. E., Fleishman, J. A., Andersen, R. M., Kellogg, T., Bozzette, S. A., (2001). Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons. Annals of Internal Medicine, 135, 557–565.
   PubMed Web of Science ®Google Scholar
• Kelly, J. A., Murphy, D. A., Bahr, G. R., Kalichman, S. C., Morgan, M. G., Stevenson, L. Y., (1993). Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons. American Journal of Psychiatry, 150, 1679–1686.
   PubMed Web of Science ®Google Scholar
• Kushel, M. B., Colfax, G., Ragland, K., Heineman, A., Palacio, H., & Bangsberg, D. R. (2006). Case management is associated with improved antiretroviral adherence and CD4+ cell counts in homeless and marginally housed individuals with HIV infection. Clinical Infectious Diseases, 43, 234–242.
   PubMed Web of Science ®Google Scholar
• Lo, W., MacGovern, T., & Bradford, J. (2002). Association of ancillary services with primary care utilization and retention for patients with HIV/AIDS. AIDS Care, 14(Suppl. 1), S45–S57.
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes, 27, 251–259.
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Mullen, B. A., McCaul, M. E., Weidle, P. J., Hader, S., & Moore, R. D. (2007). Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care and STDs, 21, 564–574.
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Mullen, B. A., Weidle, P. J., Hader, S., McCaul, M. E., & Moore, R. D. (2006). Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical Infectious Diseases, 42, 1628–1635.
   PubMed Web of Science ®Google Scholar
• Lucas, G. M., Weidle, P. J., Hader, S., & Moore, R. D. (2004). Directly administered antiretroviral therapy in an urban methadone maintenance clinic: A nonrandomized comparative study. Clinical Infectious Diseases, 38(Suppl. 5), S409–S413.
   PubMed Web of Science ®Google Scholar
• Ma, M., Brown, B. R., Coleman, M., Kibler, J. L., Loewenthal, H., & Mitty, J. A. (2008). The feasibility of modified directly observed therapy for HIV-seropositive African American substance users. AIDS Patient Care and STDs, 22, 139–146.
   PubMed Web of Science ®Google Scholar
• Macalino, G. E., Hogan, J. W., Mitty, J. A., Bazerman, L. B., Delong, A. K., Loewenthal, H., (2007). A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS, 21, 1473–1477.
   PubMed Web of Science ®Google Scholar
• Macalino, G. E., Mitty, J. A., Bazerman, L. B., Singh, K., McKenzie, M., & Flanigan, T. (2004). Modified directly observed therapy for the treatment of HIV-seropositive substance users: Lessons learned from a pilot study. Clinical Infectious Diseases, 38(Suppl. 5), S393–S397.
   PubMed Web of Science ®Google Scholar
• Magnus, M., Schmidt, N., Kirkhart, K., Schieffelin, C., Fuchs, N., Brown, B., (2001). Association between ancillary services and clinical and behavioral outcomes among HIV-infected women. AIDS Patient Care and STDs, 15, 137–145.
   PubMed Web of Science ®Google Scholar
• Malone, S. B., & Osborne, J. J. (2000). Improving treatment adherence in drug abusers who are HIV-positive. Lippincott's Case Management, 5, 236–245.
   PubMedGoogle Scholar
• Malta, M., Strathdee, S. A., Magnanini, M. F., & Bastos, F. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103, 1242–1257.
   PubMed Web of Science ®Google Scholar
• McCance-Katz, E. F., Farber, S., Selwyn, P. A., & O'Connor, A. (2000). Decrease in methadone levels with nelfinavir mesylate. American Journal of Psychiatry, 157, 481.
   PubMed Web of Science ®Google Scholar
• McCance-Katz, E. F., Gourevitch, M. N., Arnsten, J., Sarlo, J., Rainey, P., & Jatlow, P. (2002). Modified directly observed therapy (MDOT) for injection drug users with HIV disease. American Journal on Addictions, 11, 271–278.
   PubMed Web of Science ®Google Scholar
• McCance-Katz, E. F., Rainey, P. M., Friedland, G., & Jatlow, P. (2003). The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clinical Infectious Diseases, 37, 476–482.
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., (1992). The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9, 199–213.
   PubMed Web of Science ®Google Scholar
• Messeri, P. A., Abramson, D. M., Aidala, A. A., Lee, F., & Lee, G. (2002). The impact of ancillary HIV services on engagement in medical care in New York City. AIDS Care, 14(Suppl. 1), S15–S29.
   PubMed Web of Science ®Google Scholar
• Metsch, L. R., McCoy, H. V., McCoy, C. B., Miles, C. C., Edlin, B. R., & Pereyra, M. (1999). Use of health care services by women who use crack cocaine. Women Health, 30, 35–51.
   PubMed Web of Science ®Google Scholar
• Metsch, L. R., Pereyra, M., & Brewer, T. H. (2001). Use of HIV health care in HIV-seropositive crack cocaine smokers and other active drug users. Journal of Substance Abuse, 13, 155–167.
   PubMedGoogle Scholar
• Mitchell, C. G., Freels, S., Creticos, C. M., Oltean, A., & Douglas, R. (2007). Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counseling. AIDS Care, 19, 561–564.
   PubMed Web of Science ®Google Scholar
• Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190–1198.
   PubMed Web of Science ®Google Scholar
• Mund, P. A., Heller, D., Meissner, P., Matthews, D. W., Hill, M., & Cunningham, C. O. (2008). Delivering care out of the box: The evolution of an HIV harm reduction medical program. Journal of Health Care for the Poor and Underserved, 19, 944–951.
   PubMed Web of Science ®Google Scholar
• New York City Department of Health and Mental Hygiene. (2009, December 17). New York City HIV/AIDS annual surveillance statistics New York: Au. Retrieved September 24, 2010 from http://www.nyc .gov/html/doh/html/ah/hivtables.shtml
   Google Scholar
• Palacio, H., Shiboski, C. H., Yelin, E. H., Hessol, N. A., & Greenblatt, R. M. (1999). Access to and utilization of primary care services among HIV-infected women. Journal of Acquired Immune Deficiency Syndromes, 21, 293–300.
   PubMed Web of Science ®Google Scholar
• Palepu, A., Horton, N. J., Tibbetts, N., Meli, S., & Samet, J. H. (2004). Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: The impact of substance abuse treatment. Addiction, 99, 361–368.
   PubMed Web of Science ®Google Scholar
• Palepu, A., Tyndall, M. W., Joy, R., Kerr, T., Wood, E., Press, N., (2006). Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug and Alcohol Dependence, 84, 188–194.
   PubMed Web of Science ®Google Scholar
• Pollack, H. A., Khoshnood, K., Blankenship, K. M., & Altice, F. L. (2002). The impact of needle exchange-based health services on emergency department use. Journal of General Internal Medicine, 17, 341–348.
   PubMed Web of Science ®Google Scholar
• Pulvirenti, J. J., Glowacki, R., Muppiddi, U., Surapaneni, N., Gail, C., Kohl, B., (2003). Hospitalized HIV-infected patients in the HAART era: A view from the inner city. AIDS Patient Care and STDs, 17, 565–573.
   PubMed Web of Science ®Google Scholar
• Purcell, D. W., Latka, M. H., Metsch, L. R., Latkin, C. A., Gomez, C. A., Mizuno, Y., (2007). Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users. Journal of Acquired Immune Deficiency Syndromes, 46(Suppl. 2), S35–S47.
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
   Web of Science ®Google Scholar
• Rich, J. D., Holmes, L., Salas, C., Macalino, G., Davis, D., Ryczek, J., (2001). Successful linkage of medical care and community services for HIV-positive offenders being released from prison. Journal of Urban Health, 78, 279–289.
   PubMed Web of Science ®Google Scholar
• Samet, J. H., Friedmann, P., & Saitz, R. (2001). Benefits of linking primary medical care and substance abuse services: Patient, provider, and societal perspectives. Archives of Internal Medicine, 161, 85–91.
   PubMed Web of Science ®Google Scholar
• Selwyn, P. A., Budner, N. S., Wasserman, W. C., & Arno, P. S. (1993). Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Reports, 108, 492–500.
   PubMed Web of Science ®Google Scholar
• Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Senterfitt, J. W., Fleishman, J. A., Perlman, J. F., (1999). Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study. Journal of the American Medical Association, 281, 2305–2315.
   PubMed Web of Science ®Google Scholar
• Sharpe, T. T., Lee, L. M., Nakashima, A. K., Elam-Evans, L. D., & Fleming, P. L. (2004). Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. Journal of Community Health, 29, 117–127.
   PubMed Web of Science ®Google Scholar
• Shelton, M. J., Cloen, D., DiFrancesco, R., Berenson, C. S., Esch, A., de Caprariis, P. J., (2004). The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone. Journal of Clinical Pharmacology, 44, 293–304.
   PubMed Web of Science ®Google Scholar
• Sherer, R. (1998). Adherence and antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 567–568.
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Pantalone, D. W., Plummer, M. D., & Huang, B. (2007). A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychology, 26, 488–495.
   PubMed Web of Science ®Google Scholar
• Sorensen, J. L., Dilley, J., London, J., Okin, R. L., Delucchi, K. L., & Phibbs, C. S. (2003). Case management for substance abusers with HIV/AIDS: A randomized clinical trial. American Journal of Drug and Alcohol Abuse, 29, 133–150.
   PubMed Web of Science ®Google Scholar
• Spire, B., Lucas, G. M., & Carrieri, M. P. (2007). Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). International Journal of Drug Policy, 18, 262–270.
   PubMed Web of Science ®Google Scholar
• Stevens, R. C., Rapaport, S., Maroldo-Connelly, L., Patterson, J. B., & Bertz, R. (2003). Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir. Journal of Acquired Immune Deficiency Syndromes, 33, 650–651.
   PubMed Web of Science ®Google Scholar
• Strathdee, S. A., Palepu, A., Cornelisse, P. G., Yip, B., O'Shaughnessy, M. V., Montaner, J. S., (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547–549.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2009). Substance abuse treatment facility locator. Retrieved March 18, 2009, from http://findtreatment.samhsa .gov/list_search.htm
   Google Scholar
• Sullivan, L. E., Barry, D., Moore, B. A., Chawarski, M. C., Tetrault, J. M., Pantalon, M. V., (2006). A Trial of integrated buprenorphine/naloxone and HIV clinical care. Clinical Infectious Diseases, 43(Suppl. 4), S184–S190.
   PubMed Web of Science ®Google Scholar
• Sullivan, L. E., Tetrault, J., Bangalore, D., & Fiellin, D. A. (2006). Training HIV physicians to prescribe buprenorphine for opioid dependence. Substance Abuse, 27, 13–18.
   PubMedGoogle Scholar
• Summers, J., Robinson, R., Capps, L., Zisook, S., Atkinson, J. H., McCutchan, E., (2000). The influence of HIV-related support groups on survival in women who lived with HIV. A pilot study. Psychosomatics, 41, 262–268.
   PubMed Web of Science ®Google Scholar
• Tinoco, I., Giron-Gonzalez, J. A., Gonzalez-Gonzalez, M. T., Vergara de, C. A., Rodriguez-Felix, L., Serrano, A., (2004). Efficacy of directly observed treatment of HIV infection: Experience in AIDS welfare homes. European Journal of Clinical Microbiology & Infectious Diseases, 23, 331–335.
   PubMed Web of Science ®Google Scholar
• Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F. Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114, 573–580.
   PubMed Web of Science ®Google Scholar
• Turner, B. J., Fleishman, J. A., Wenger, N., London, A. S., Burnam, M. A., Shapiro, M. F., (2001). Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16, 625–633.
   PubMed Web of Science ®Google Scholar
• Turner, B. J., Laine, C., Lin, Y. T., & Lynch, K. (2005). Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. Archives of Internal Medicine, 165, 1769–1776.
   PubMed Web of Science ®Google Scholar
• Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233.
   PubMed Web of Science ®Google Scholar
• Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., (1994). The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. New England Journal of Medicine, 330, 1179–1184.
   PubMed Web of Science ®Google Scholar
• Willenbring, M. L. (2005). Integrating care for patients with infectious, psychiatric, and substance use disorders: Concepts and approaches. AIDS, 19(Suppl. 3), S227–S237.
   PubMed Web of Science ®Google Scholar
• Wohl, A. R., Garland, W. H., Squires, K., Witt, M., Larsen, R., Kovacs, A., (2004). The feasibility of a community-based directly administered antiretroviral therapy program. Clinical Infectious Diseases, 38(Suppl. 5), S388–S392.
   PubMed Web of Science ®Google Scholar